Dataset from An Open-label, Multicenter Phase II Study to Assess the Response of Subjects With Metastatic Breast Cancer Previously Treated With Anthracycline and Taxane Therapy With or Without Capecitabine to ZD6474 (100-mg or 300-mg Daily Oral Dose).
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00007698
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to assess the efficacy of ZD6474 in patients with metastatic
breast cancer at 2 dose levels.
创建时间：
2024-11-26
